Efficacy and Safety of Alemtuzumab in Patients of African Descent with Relapsing-Remitting Multiple Sclerosis: 8-Year Follow-up of CARE-MS I and II (TOPAZ Study)
Titel:
Efficacy and Safety of Alemtuzumab in Patients of African Descent with Relapsing-Remitting Multiple Sclerosis: 8-Year Follow-up of CARE-MS I and II (TOPAZ Study)
Auteur:
Okai, Annette F. Amezcua, Lilyana Berkovich, Regina R. Chinea, Angel R. Edwards, Keith R. Steingo, Brian Walker, Aljoeson Jacobs, Alan K. Daizadeh, Nadia Williams, Mitzi J.